Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Unknown 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3Thoracic 2Genitourinary 1Gastrointestinal 1

Conditions

Advanced Malignant Solid Tumors 3

Interventions

Injections 98pembrolizumab 90Carboplatin 57Paclitaxel 54Cisplatin 52Nivolumab 44Docetaxel 43Pemetrexed 42Gemcitabine 37atezolizumab 32tislelizumab 29Bevacizumab 29toripalimab 23Fluorouracil 23Capecitabine 23Irinotecan 22Oxaliplatin 20durvalumab 19Ipilimumab 18Leucovorin 17Cetuximab 17Rifampin 14Itraconazole 14olaparib 13spartalizumab 12Midazolam 12Cyclophosphamide 12trifluridine tipiracil drug combination 11sintilimab 11Drug Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × vorolanib × Other solid neoplasm × Clear all
NCT03792958 2022-11-14

Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors

AnewPharma

Phase 1 Unknown
19 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04328506 2021-11-26

Bioequivalency Study of CM082 Tablet in Healthy Volunteers

AnewPharma

Phase 1 Completed
96 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

NCT04126668 2020-05-21

A Study to Investigate the Food Effect on the Pharmacokinetics of CM082 Tablet in Chinese Healthy Volunteers

AnewPharma

Phase 1 Completed
24 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡